Emporio Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-11-2024
- Paid Up Capital ₹ 0.10 M
as on 07-11-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.85 Cr
as on 07-11-2024
- Revenue 306.58%
(FY 2023)
- Profit 79.69%
(FY 2023)
- Ebitda 65.12%
(FY 2023)
- Net Worth 121.35%
(FY 2023)
- Total Assets 50.98%
(FY 2023)
About Emporio Lifesciences
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.85 Cr.
Vinay Shridhar and Preeti Shridhar serve as directors at the Company.
- CIN/LLPIN
U36990UR2021PTC012520
- Company No.
012520
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Emporio Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Shridhar  | Director | 17-Jun-2021 | Current |
| Preeti Shridhar | Director | 17-Jun-2021 | Current |
Financial Performance of Emporio Lifesciences.
Emporio Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 306.58% increase. The company also saw a substantial improvement in profitability, with a 79.69% increase in profit. The company's net worth Soared by an impressive increase of 121.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emporio Lifesciences?
Unlock access to Emporio Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 21 May 2024 | ₹1.50 Cr | Open |
Axis Bank Limited Creation Date: 20 Nov 2023 | ₹3.50 M | Open |
How Many Employees Work at Emporio Lifesciences?
Emporio Lifesciences has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emporio Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emporio Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
